Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Casdin Capital and Genmark Diagnostics Inc. (GNMK)

Genmark Diagnostics Inc. (NASDAQ:GNMK): Eli Casdin’s Casdin Capital filed an amended 13D.

You can check out Casdin Capital’s latest holdings and filings here.

Please follow Casdin Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Casdin Capital or update its stock holdings.

Eli Casdin
Eli Casdin
Casdin Capital

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Casdin Capital 0 3,850,000 0 3,850,000 3,850,000 7.0%
Casdin Partners Master Fund 0 3,850,000 0 3,850,000 3,850,000 7.0%
Casdin Partners GP 0 3,850,000 0 3,850,000 3,850,000 7.0%
Eli Casdin 0 3,850,000 0 3,850,000 3,850,000 7.0%
Eli Casdin
Eli Casdin
Casdin Capital

Page 1 of 11 – SEC Filing



DC 20549



(Amendment No.)*

GenMark Diagnostics, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value
(Title of Class of Securities)
(CUSIP Number)

Eli Casdin

Casdin Capital, LLC

1350 Avenue of the Americas, Suite 2405

New York, New York

Telephone Number (212) 897-5438

(Name, Address and Telephone Number of Person
Authorized to Receive

Notices and Communications)

March 20, 2018
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [_].
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
Follow Genmark Diagnostics Inc. (NASDAQ:GNMK)
Trade (NASDAQ:GNMK) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.